Celltech Group , the independent biotechnology company , halved pre-tax losses and intends to seek a listing for its shares by 1994 . A loss of Pounds 6.58m ( Pounds 12.5m ) was incurred for the year to September 30 , on turnover of Pounds 17m ( Pounds 19.9m ) . The company has completed a restructuring programme and its research is now focused on projects aimed at large markets such as cancer therapy and transplant technology .